Active Grant Awards
Dr. Vladimir Badovinac has a new collaborating research agreement with Dr. Thomas Griffith from the Minneapolis VA Health Care System. The title of this project is Suppression of T cell immunity during sepsis. The contract total is $108,523. This contract is for the period of October 1, 2012 and should be complete by September 30, 2014.
Dr. Daniel Diekema has a new research contract negotiated with bioMerieux, Inc. for a research project titled VITEK 2 and VITEK 2 Compact AF03 Antifungal Susceptibility Tests. The contract total is $79,225. This contract is for the period of July 1, 2012 through July 1, 2013.
Dr. Daniel Diekema has a continuation of research contract negotiated with Cerexa, Inc. for a research project titled Tracking Resistance in Streptococcus pneumonia (TRISP II). The contract total is $334,500. This contract is for the period of June 26, 2012 through August 15, 2013.
Dr. Nitin Karandikar received a notice of grant funding from the National Multiple Sclerosis Society. The title of this project is Role of CNS-Specific Autoreactive CD8+ T Cells in MS. The amount of this award is $712,800. The period for this project is April 1, 2013 through March 31, 2017.
Dr. Nitin Karandikar received grant funding for a one year continuation from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Role of T cells in the immunomodulation of MS. The total direct costs for this award are$127,397. The period for this project is February 1, 2013 through January 31, 2014.
Dr. Nitin Karandikar received grant funding from the National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is CNS-specific Regulatory CD8+ T cells in autoimmune demyelination. The total direct costs for this award are$1,125,000. The period for this project is May 1, 2011 through April 30, 2016.
Dr. Nitin Karandikar received grant funding from National Institute of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID). The title of this project is Dissecting the Immunologic Basis of Health and Disease. The total direct costs for this award are $845,020. The period for this project is March 1, 2009 through February 28, 2014.
Dr. C. Michael Knudson received funding under the Carver College of Medicine Internal Funding Opportunity for High Throughput Screening. The award is in the amount of $10,000.
Dr. Deqin Ma has a new research contract negotiated with Ventana Medical Systems, Inc. for a research project titled CINtec Histology Study. The contract total is $15,000. This contract is for the period of October 8, 2012 and should be complete by December 31, 2013.
Dr. Andrean Simons-Burnett received an American Cancer Society (ACS) Seed Grant Award from the Holden Comprehensive Cancer Center at the University of Iowa. The title of the project is NOX4-mediated autophagy and glucose metabolism associated with resistance to Erlotinib in HNSCC. The amount of this award is $30,000. The period for this project is July 1, 2012 through June 30, 2013.
Dr. Weizhou Zhang received a notice of R00 funding from the National Institutes of Health. The title of the project is Myofibroblasts, T Cells and Malignant Cells Interplay in Breast Cancer Metastasis. This award is for the period of July 1, 2012 through June 30, 2015. The amount of this award is $735,752.